日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics

一项随机对照试验,旨在评估mySmartSkin网络干预措施在促进黑色素瘤患者进行皮肤自检和防晒行为方面的效果:研究设计和基线特征

Coups, Elliot J; Manne, Sharon L; Ohman Strickland, Pamela; Hilgart, Michelle; Goydos, James S; Heckman, Carolyn J; Chamorro, Paola; Rao, Babar K; Davis, Moira; Smith, Franz O; Thorndike, Frances P; Ritterband, Lee M

Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo

xCT 参与黑色素瘤细胞体外增殖和体内肿瘤形成

Seung-Shick Shin, Byeong-Seon Jeong, Brian A Wall, Jiadong Li, Naing Lin Shan, Yu Wen, James S Goydos, Suzie Chen

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

利鲁唑(一种代谢型谷氨酸受体 1 (GRM1) 信号通路拮抗剂)治疗晚期黑色素瘤患者的 II 期临床试验

Mehnert, Janice M; Silk, Ann W; Lee, J H; Dudek, Liesel; Jeong, Byeong-Seon; Li, Jiadong; Schenkel, Jason M; Sadimin, Evita; Kane, Michael; Lin, Hongxia; Shih, Weichung J; Zloza, Andrew; Chen, Suzie; Goydos, James S

Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo

突变的 BRaf (V600E) 在体外和体内激活 Grm1 表达

Ho-Chung Chen, Jairo Sierra, Lumeng Jenny Yu, Robert Cerchio Jr, Brian A Wall, James Goydos, Suzie Chen

Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness

表达代谢型谷氨酸受体 1 (GRM1) 的黑色素瘤细胞释放的外泌体可增加细胞迁移和侵袭性

Allison L Isola, Kevinn Eddy, Krzysztof Zembrzuski, James S Goydos, Suzie Chen

Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy

Sunbelt黑色素瘤试验的最终结果:一项多中心前瞻性随机III期研究,评估辅助高剂量干扰素α-2b和完成淋巴结清扫术对前哨淋巴结活检分期患者的作用

McMasters, Kelly M; Egger, Michael E; Edwards, Michael J; Ross, Merrick I; Reintgen, Douglas S; Noyes, R Dirk; Martin, Robert C G 2nd; Goydos, James S; Beitsch, Peter D; Urist, Marshall M; Ariyan, Stephan; Sussman, Jeffrey J; Davidson, B Scott; Gershenwald, Jeffrey E; Hagendoorn, Lee J; Stromberg, Arnold J; Scoggins, Charles R

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma

转录因子 RUNX2 调节黑色素瘤中受体酪氨酸激酶的表达

Rajeev K Boregowda, Daniel J Medina, Elke Markert, Michael A Bryan, Wenjin Chen, Suzie Chen, Anna Rabkin, Michael J Vido, Samuel I Gunderson, Marina Chekmareva, David J Foran, Ahmed Lasfar, James S Goydos, Karine A Cohen-Solal0

Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression

靶向谷氨酸信号和 PI3 激酶通路来阻止黑色素瘤进展

Stephen A Rosenberg, Scot A Niglio, Negar Salehomoum, Joseph L-K Chan, Byeong-Seon Jeong, Yu Wen, Jiadong Li, Jami Fukui, Suzie Chen, Seung-Shick Shin, James S Goydos

Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells

在源自表达GRM1的人类黑色素瘤细胞的脑转移体内模型中,利鲁唑是一种放射增敏剂。

Wall, Brian A; Yu, Lumeng J; Khan, Atif; Haffty, Bruce; Goydos, James S; Chen, Suzie

Occupational sunscreen use among US Hispanic outdoor workers

美国西班牙裔户外工作者职业防晒霜使用情况

Day, Ashley K; Stapleton, Jerod L; Natale-Pereira, Ana M; Goydos, James S; Coups, Elliot J